Literature DB >> 2947676

Hematopoiesis and suppressor bone marrow cells in mice bearing large metastatic Lewis lung carcinoma tumors.

M R Young, M Newby, H T Wepsic.   

Abstract

Mice bearing a metastatic variant of Lewis lung carcinoma (LLC-C3) were studied to determine if there might be a relationship between tumor induced hematopoiesis and immune suppression. Growth of LLC-C3 in C57BL/6 mice corresponded with increased hematopoiesis and an increase in the proportion of monocytes in the peripheral blood, spleen, and bone marrow. The LLC-C3 cells secreted colony stimulating factor activity and, thus, could have directly stimulated the hematopoiesis in the hosts. As tumor growth progressed, the bone marrow of the tumor bearing mice became suppressive to T-cell blastogenesis. The bone marrow suppressor cells obtained from mice bearing large (greater than 3 g) LLC-C3 tumors were nonadherent to nylon wool, sensitive to treatment with L-leucine methyl ester, insensitive to treatment with anti-Thy-1.2 and complement, and mediated their suppression through an indomethacin sensitive mechanism. Secretion of colony stimulating factor activity by the LLC-C3 cells could have induced the appearance of the bone marrow suppressor cells since normal bone marrow cells which were cultured in the presence of LLC-C3 culture supernatants had an increased proportion of monocytes and were suppressive to T-lymphocyte blastogenesis. Our results suggest that the colony stimulating factor activity produced by LLC-C3 cells stimulates hematopoiesis which, in turn, could result in the appearance of bone marrow suppressor cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2947676

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  76 in total

1.  Tumor-derived cytokines induce bone marrow suppressor cells that mediate immunosuppression through transforming growth factor beta.

Authors:  M R Young; M A Wright; M Coogan; M E Young; J Bagash
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

2.  Myeloid suppressor cells induced by retinal pigment epithelial cells inhibit autoreactive T-cell responses that lead to experimental autoimmune uveitis.

Authors:  Zhidan Tu; Yan Li; Dawn Smith; Catherine Doller; Sunao Sugita; Chi-Chao Chan; Shiguang Qian; John Fung; Rachel R Caspi; Lina Lu; Feng Lin
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-02-23       Impact factor: 4.799

Review 3.  Role of myeloid-derived suppressor cells in allogeneic hematopoietic cell transplantation.

Authors:  Brent H Koehn; Bruce R Blazar
Journal:  J Leukoc Biol       Date:  2017-02-01       Impact factor: 4.962

Review 4.  Advancements in immune tolerance.

Authors:  Ping-Ying Pan; Junko Ozao; Zuping Zhou; Shu-Hsia Chen
Journal:  Adv Drug Deliv Rev       Date:  2007-10-05       Impact factor: 15.470

5.  Δ⁹-Tetrahydrocannabinol attenuates allogeneic host-versus-graft response and delays skin graft rejection through activation of cannabinoid receptor 1 and induction of myeloid-derived suppressor cells.

Authors:  Jessica M Sido; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  J Leukoc Biol       Date:  2015-06-01       Impact factor: 4.962

6.  MDSC: a new player in HIV immunopathogenesis.

Authors:  Bernard J C Macatangay; Alan L Landay; Charles R Rinaldo
Journal:  AIDS       Date:  2012-07-31       Impact factor: 4.177

7.  Lack of a relationship between immune function and chemically induced hepatocarcinogenesis in B6C3F1 mice.

Authors:  D R Germolec; R R Maronpot; M F Ackermann; S J Vore; K Dittrich; G J Rosenthal; M I Luster
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

8.  Increasing infiltration and activation of CD8+ tumor-infiltrating lymphocytes after eliminating immune suppressive granulocyte/macrophage progenitor cells with low doses of interferon gamma plus tumor necrosis factor alpha.

Authors:  M R Young; G McCloskey; M A Wright; A S Pak
Journal:  Cancer Immunol Immunother       Date:  1994-01       Impact factor: 6.968

Review 9.  Myeloid-derived suppressor cells: a novel therapeutic target.

Authors:  Jennifer S Ko; Ronald M Bukowski; James H Fincke
Journal:  Curr Oncol Rep       Date:  2009-03       Impact factor: 5.075

10.  Anti-Gr-1 antibody depletion fails to eliminate hepatic myeloid-derived suppressor cells in tumor-bearing mice.

Authors:  Chi Ma; Tamar Kapanadze; Jaba Gamrekelashvili; Michael P Manns; Firouzeh Korangy; Tim F Greten
Journal:  J Leukoc Biol       Date:  2012-10-17       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.